Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
23andMe (United States)
Sunnyvale, United States
University College Cork
Cork, Ireland
University of North Carolina at Chapel Hill
Chapel Hill, United States
University of Leeds
Leeds, United Kingdom
KU Leuven
Leuven, Belgium
University of Michigan
Ann Arbor, United States
Mayo Clinic
Rochester, United States
University of California, Los Angeles
Los Angeles, United States
King's College London
London, United Kingdom
University of Gothenburg
Gothenburg, Sweden
References
References (100)
- 1
Two gastrointestinal conditions with similar symptoms and endoscopic appearance: irritable bowel syndrome and microscopic colitis.
Şimşek Z, Tuncer NC, Alagüzlü H, et al.
Turkish journal of medical sciences 2015; (45(2)):393-7 doi:10.3906/sag-1401-88.
PMID: 26084132 - 2
[Evolution of ideas on microscopic colitis].
Maev IV, Kucheryavyi YA, Andreev DN, Cheremushkin SV
Terapevticheskii arkhiv 2015; (87(4)):69-76 doi:10.17116/terarkh201587469-76.
PMID: 26087638 - 3
Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.
Pimentel M
Alimentary pharmacology & therapeutics 2016; (43 Suppl 1()):37-49 doi:10.1111/apt.13437.
PMID: 26618924 - 4
Review article: bile acid diarrhoea - pathogenesis, diagnosis and management.
Mottacki N, Simrén M, Bajor A
Alimentary pharmacology & therapeutics 2016; (43(8)):884-898 doi:10.1111/apt.13570.
PMID: 26913381 - 5
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.
Foxx-Orenstein AE
Therapeutic advances in gastroenterology 2016; (9(3)):354-75 doi:10.1177/1756283X16633050.
PMID: 27134665 - 6
Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
Patel A, Hasak S, Cassell B, et al.
Alimentary pharmacology & therapeutics 2016; (44(3)):246-58 doi:10.1111/apt.13677.
PMID: 27240555 - 7
Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome.
Peters SL, Yao CK, Philpott H, et al.
Alimentary pharmacology & therapeutics 2016; (44(5)):447-59 doi:10.1111/apt.13706.
PMID: 27397586 - 8
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Lembo A, Pimentel M, Rao SS, et al.
Gastroenterology 2016; (151(6)):1113-1121 doi:10.1053/j.gastro.2016.08.003.
PMID: 27528177 - 9
Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
Peleman C, Camilleri M, Busciglio I, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017; (15(5)):720-727.e1 doi:10.1016/j.cgh.2016.11.012.
PMID: 27856362 - 10
Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.
Xu XJ, Zhang YL, Liu L, et al.
Alimentary pharmacology & therapeutics 2017; (45(1)):100-114 doi:10.1111/apt.13848.
PMID: 27862119 - 11
The Place of Stress and Emotions in the Irritable Bowel Syndrome.
Pellissier S, Bonaz B
Vitamins and hormones 2017; (103()):327-354 doi:10.1016/bs.vh.2016.09.005.
PMID: 28061975 - 12
Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patients.
Gericke B, Amiri M, Scott CR, Naim HY
Biochimica et biophysica acta. Molecular basis of disease 2017; (1863(3)):817-826 doi:10.1016/j.bbadis.2016.12.017.
PMID: 28062276 - 13
Improved Starch Digestion of Sucrase-deficient Shrews Treated With Oral Glucoamylase Enzyme Supplements.
Nichols BL, Avery SE, Quezada-Calvillo R, et al.
Journal of pediatric gastroenterology and nutrition 2017; (65(2)):e35-e42 doi:10.1097/MPG.0000000000001561.
PMID: 28267073 - 14
Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros.
Ghoshal UC
Journal of neurogastroenterology and motility 2017; (23(3)):334-340 doi:10.5056/jnm17020.
PMID: 28672432 - 15
Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
Vork L, Weerts ZZRM, Mujagic Z, et al.
Neurogastroenterology and motility 2018; (30(2)) doi:10.1111/nmo.13189.
PMID: 28804974 - 16
Clinical Characteristics of Disaccharidase Deficiencies Among Children Undergoing Upper Endoscopy.
Cohen SA, Oloyede H, Gold BD, et al.
Journal of pediatric gastroenterology and nutrition 2018; (66 Suppl 3()):S56-S60 doi:10.1097/MPG.0000000000001961.
PMID: 29762380 - 17
[Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, and quality of life in patients with irritable bowel syndrome in Colombia].
Yepes IJ, Múnera MN, Martelo C
Biomedica : revista del Instituto Nacional de Salud 2018; (38(0)):61-68 doi:10.7705/biomedica.v38i0.3443.
PMID: 29809329 - 18
Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease.
Vakil N
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2018; (33(4)):468-475 doi:10.1002/ncp.10108.
PMID: 29870082 - 19
Pathogenic Factors in Postinfectious Irritable Bowel Syndrome - An Update.
Iacob T, Ţăţulescu DF, Cijevschi Prelipcean C, Dumitraşcu DL
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2016; (120(3)):515-21.
PMID: 30044574 - 20
Small Intestinal Bacterial Overgrowth Syndrome Prevalence in Romanian Patients with Inflammatory Bowel Disease.
Andrei M, Gologan S, Stoicescu A, et al.
Current health sciences journal 2016; (42(2)):151-156 doi:10.12865/CHSJ.42.02.06.
PMID: 30568826 - 21
Eluxadoline-induced Recurrent Pancreatitis in a Young Female without a Gallbladder: A Case Report and Literature Review.
Khetpal N, Yadav L, Khalid S, Kumar R
Cureus 2018; (10(12)):e3747 doi:10.7759/cureus.3747.
PMID: 30820368 - 22
Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life.
Paduano D, Cingolani A, Tanda E, Usai P
Nutrients 2019; (11(7)) doi:10.3390/nu11071566.
PMID: 31336747 - 23
Relationship between Stool Form and Quality of Life in Patients with Chronic Constipation: An Internet Questionnaire Survey.
Ohkubo H, Yoshihara T, Misawa N, et al.
Digestion 2021; (102(2)):147-154 doi:10.1159/000502815.
PMID: 31574514 - 24
Stool Consistency: Looking Beyond the Bristol Stool Form Scale.
Vork L, Wilms E, Penders J, Jonkers DMAE
Journal of neurogastroenterology and motility 2019; (25(4)):625 doi:10.5056/jnm19086.
PMID: 31587553 - 25
Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea.
Brenner DM, Sayuk GS
Advances in therapy 2020; (37(1)):83-96 doi:10.1007/s12325-019-01116-z.
PMID: 31707713 - 26
Randomised clinical trial: linaclotide vs placebo-a study of bi-directional gut and brain axis.
Rao SSC, Xiang X, Yan Y, et al.
Alimentary pharmacology & therapeutics 2020; (51(12)):1332-1341 doi:10.1111/apt.15772.
PMID: 32406112 - 27
The Role of Bile Acids in Chronic Diarrhea.
Camilleri M, Vijayvargiya P
The American journal of gastroenterology 2020; (115(10)):1596-1603 doi:10.14309/ajg.0000000000000696.
PMID: 32558690 - 28
Preliminary Study on the Tears Oxidative Stress Status and Sleep Disturbances in Irritable Bowel Syndrome Patients.
Balmus IM, Cojocariu RO, Ciobica A, et al.
Oxidative medicine and cellular longevity 2020; (2020()):4690713 doi:10.1155/2020/4690713.
PMID: 32566082 - 29
Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial.
Basnayake C, Kamm MA, Stanley A, et al.
The lancet. Gastroenterology & hepatology 2020; (5(10)):890-899 doi:10.1016/S2468-1253(20)30215-6.
PMID: 32679040 - 30
Management of Irritable Bowel Syndrome: Physician-Dietitian Collaboration.
Ireton-Jones C, Weisberg MF
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2020; (35(5)):826-834 doi:10.1002/ncp.10567.
PMID: 32786046 - 31
Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome.
Chey WD, Keefer L, Whelan K, Gibson PR
Gastroenterology 2021; (160(1)):47-62 doi:10.1053/j.gastro.2020.06.099.
PMID: 33091411 - 32
Low Fermentable Oligo- Di- and Mono-Saccharides and Polyols (FODMAPs) or Gluten Free Diet: What Is Best for Irritable Bowel Syndrome?
Bellini M, Tonarelli S, Mumolo MG, et al.
Nutrients 2020; (12(11)) doi:10.3390/nu12113368.
PMID: 33139629 - 33
[Is the diet low in FODMAP really effective and safe for irritable bowel syndrome?: A scoping review].
Sebastián Domingo JJ, Sánchez Sánchez C
Semergen 2020; (46(8)):566-576 doi:10.1016/j.semerg.2020.07.010.
PMID: 33153877 - 34
Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
Lyutakov I, Lozanov V, Sugareva P, et al.
European journal of gastroenterology & hepatology 2021; (33(3)):380-387 doi:10.1097/MEG.0000000000001925.
PMID: 33177381 - 35
Appropriateness of colonoscopy at a tertiary care centre - are we overdoing gastrointestinal endoscopy?
Čustović N, Džananović L, Rašić I, et al.
Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina 2021; (18(1)):84-89 doi:10.17392/1248-21.
PMID: 33219637 - 36
ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
Lacy BE, Pimentel M, Brenner DM, et al.
The American journal of gastroenterology 2021; (116(1)):17-44 doi:10.14309/ajg.0000000000001036.
PMID: 33315591 - 37
Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.
Goyal O, Batta S, Nohria S, et al.
Journal of gastroenterology and hepatology 2021; (36(8)):2107-2115 doi:10.1111/jgh.15410.
PMID: 33464683 - 38
The Microbiota-Gut-Brain Axis: From Motility to Mood.
Margolis KG, Cryan JF, Mayer EA
Gastroenterology 2021; (160(5)):1486-1501 doi:10.1053/j.gastro.2020.10.066.
PMID: 33493503 - 39
Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis.
Shah ED, Salwen-Deremer JK, Gibson PR, et al.
MDM policy & practice 2021; (6(1)):2381468320978417 doi:10.1177/2381468320978417.
PMID: 33521290 - 40
Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study.
Flores V, Martínez-Lozano H, Bighelli F, et al.
BMC gastroenterology 2021; (21(1)):56 doi:10.1186/s12876-021-01637-4.
PMID: 33563227 - 41
Sucrase-Isomaltase Deficiency Causing Persistent Bloating and Diarrhea in an Adult Female.
Chiruvella V, Cheema A, Arshad HMS, et al.
Cureus 2021; (13(4)):e14349 doi:10.7759/cureus.14349.
PMID: 33972906 - 42
A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome.
Nulsen B, LeBrett W, Drossman DA, Chang L
Alimentary pharmacology & therapeutics 2021; (54(3)):281-291 doi:10.1111/apt.16467.
PMID: 34148256 - 43
Chronic stress and poor sleeping habits are associated with self-reported IBS and poor psychological well-being in the general population.
Zejnelagic J, Ohlsson B
BMC research notes 2021; (14(1)):280 doi:10.1186/s13104-021-05688-4.
PMID: 34294119 - 44
Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation.
Liu JJ, Brenner DM
Gastroenterology clinics of North America 2021; (50(3)):639-653 doi:10.1016/j.gtc.2021.04.004.
PMID: 34304792 - 45
Pain and psyche in a patient with irritable bowel syndrome: chicken or egg? A time series case report.
Engel F, Stadnitski T, Stroe-Kunold E, et al.
BMC gastroenterology 2021; (21(1)):309 doi:10.1186/s12876-021-01879-2.
PMID: 34344311 - 46
Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review.
Tang HY, Jiang AJ, Wang XY, et al.
Annals of translational medicine 2021; (9(14)):1187 doi:10.21037/atm-21-2779.
PMID: 34430628 - 47
Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome.
Staudacher HM, Rossi M, Kaminski T, et al.
Neurogastroenterology and motility 2022; (34(4)):e14241 doi:10.1111/nmo.14241.
PMID: 34431172 - 48
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders.
Eijsbouts C, Zheng T, Kennedy NA, et al.
Nature genetics 2021; (53(11)):1543-1552 doi:10.1038/s41588-021-00950-8.
PMID: 34741163 - 49
Commonly used biomarkers do not contribute to diagnosing irritable bowel syndrome.
Kramer S, Masclee AAM, Jebbink RJA, Tack GJ
European journal of gastroenterology & hepatology 2022; (34(3)):302-307 doi:10.1097/MEG.0000000000002312.
PMID: 34775459 - 50
Review article: current and future treatment approaches for pain in IBS.
Paine P
Alimentary pharmacology & therapeutics 2021; (54 Suppl 1()):S75-S88 doi:10.1111/apt.16550.
PMID: 34927753 - 51
Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS-D) and IBS mixed pattern (IBS-M).
Nee J, Lembo A
Alimentary pharmacology & therapeutics 2021; (54 Suppl 1()):S63-S74 doi:10.1111/apt.16625.
PMID: 34927757 - 52
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
Chang L, Sultan S, Lembo A, et al.
Gastroenterology 2022; (163(1)):118-136 doi:10.1053/j.gastro.2022.04.016.
PMID: 35738724 - 53
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
Lembo A, Sultan S, Chang L, et al.
Gastroenterology 2022; (163(1)):137-151 doi:10.1053/j.gastro.2022.04.017.
PMID: 35738725 - 54
Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?
Mittal A, Gupta S, Afridi F, et al.
Cureus 2022; (14(5)):e25137 doi:10.7759/cureus.25137.
PMID: 35747043 - 55
Impact of Rome IV irritable bowel syndrome on work and activities of daily living.
Goodoory VC, Ng CE, Black CJ, Ford AC
Alimentary pharmacology & therapeutics 2022; (56(5)):844-856 doi:10.1111/apt.17132.
PMID: 35794733 - 56
Irritable Bowel Syndrome: A Multifaceted World Still to Discover.
Bassotti G
Journal of clinical medicine 2022; (11(14)) doi:10.3390/jcm11144103.
PMID: 35887869 - 57
Organic colonic lesions in patients with irritable bowel syndrome: A comparative study.
Ejtehadi F, Anbardar MH, Imanieh MH, et al.
Revista de gastroenterologia de Mexico (English) 2023; (88(3)):208-213 doi:10.1016/j.rgmxen.2022.07.007.
PMID: 35906157 - 58
Modest Conformity Between Self-Reporting of Bristol Stool Form and Fecal Consistency Measured by Stool Water Content in Irritable Bowel Syndrome and a FODMAP and Gluten Trial.
Nordin E, Hellström PM, Brunius C, Landberg R
The American journal of gastroenterology 2022; (117(10)):1668-1674 doi:10.14309/ajg.0000000000001942.
PMID: 36087104 - 59
Healthy sleep, mental health, genetic susceptibility, and risk of irritable bowel syndrome.
Liu M, Ye Z, Wu Q, et al.
Journal of affective disorders 2023; (331()):25-32 doi:10.1016/j.jad.2023.03.033.
PMID: 36934852 - 60
Differential Diagnosis of Chronic Diarrhea: An Algorithm to Distinguish Irritable Bowel Syndrome With Diarrhea From Other Organic Gastrointestinal Diseases, With Special Focus on Exocrine Pancreatic Insufficiency.
Brenner DM, Domínguez-Muñoz JE
Journal of clinical gastroenterology 2023; (57(7)):663-670 doi:10.1097/MCG.0000000000001855.
PMID: 37115854 - 61
Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults-A Narrative Review.
Morariu ID, Avasilcai L, Vieriu M, et al.
Nutrients 2023; (15(10)) doi:10.3390/nu15102295.
PMID: 37242178 - 62
Prospective comparison of diagnostic tests for bile acid diarrhoea.
Borup C, Vinter-Jensen L, Jørgensen SPG, et al.
Alimentary pharmacology & therapeutics 2024; (59(1)):39-50 doi:10.1111/apt.17739.
PMID: 37794830 - 63
Fecal calprotectin in cirrhosis-Does "ESR" of the intestine measure the liver dysfunction too?
Jena A, Sharma V, Dutta U
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2023; (42(6)):754-756 doi:10.1007/s12664-023-01481-2.
PMID: 37999894 - 64
Post-infection irritable bowel syndrome following Coronavirus disease-19: A systematic review and meta-analysis.
Mathur A, Shams U, Mishra P, et al.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2024; (43(3)):557-566 doi:10.1007/s12664-023-01486-x.
PMID: 38261245 - 65
Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.
Lembo AJ, Chey WD, Harris LA, et al.
The American journal of gastroenterology 2024; (119(5)):937-945 doi:10.14309/ajg.0000000000002685.
PMID: 38294158 - 66
Anxiety-Related Factors Associated With Symptom Severity in Irritable Bowel Syndrome in Jazan, Saudi Arabia.
Alhazmi A, Darraj H, Abdali H, et al.
Cureus 2024; (16(2)):e53549 doi:10.7759/cureus.53549.
PMID: 38445128 - 67
Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When.
Hanna-Jairala I, Drossman DA
The American journal of gastroenterology 2024; (119(7)):1272-1284 doi:10.14309/ajg.0000000000002800.
PMID: 38595149 - 68
Intensive short-term dynamic psychotherapy for irritable bowel syndrome: a randomized controlled trial examining improvements in emotion regulation, defense mechanisms, quality of life, and IBS symptoms.
Shafiei F, Dehghani M, Lavasani FF, et al.
Frontiers in psychology 2024; (15()):1293150 doi:10.3389/fpsyg.2024.1293150.
PMID: 38605838 - 69
[Bile Acid Diarrhea].
Kim HJ, Kim HJ
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2024; (83(4)):133-142 doi:10.4166/kjg.2023.119.
PMID: 38659249 - 70
All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome.
Eswaran S, Jencks KJ, Singh P, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2025; (23(2)):351-358.e5 doi:10.1016/j.cgh.2024.03.047.
PMID: 38729390 - 71
Causative Factors, Clinical Manifestations, and Therapeutic Strategies for Irritable Bowel Syndrome.
Anand K, Khatib MN
Cureus 2024; (16(4)):e58728 doi:10.7759/cureus.58728.
PMID: 38779277 - 72
Impact of mechanical barrier damage and interleukin-17 on symptoms in patients with post-infectious irritable bowel syndrome.
Zhao J, Dai Y, Tian J, et al.
British journal of hospital medicine (London, England : 2005) 2024; (85(7)):1-13 doi:10.12968/hmed.2024.0114.
PMID: 39078895 - 73
Congenital Sucrase-Isomaltase Deficiency: Same Mutation with Different Clinical Presentations.
İryancı Fİ, Güven B, Çakır M
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2024; (35(4)):343-349 doi:10.5152/tjg.2024.23250.
PMID: 39128102 - 74
Functional Bowel Disorder Management in Routine Practice with Tips for Hot Topics: Expert Opinion Review.
Akyüz F, Çelebi A, Doğan İ, et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2024; (35(6)):423-439 doi:10.5152/tjg.2024.24029.
PMID: 39128123 - 75
The sucrose challenge symptoms test optimized for diagnosis of congenital sucrase isomaltase deficiency.
Street K, Tao W, Cash B, et al.
PloS one 2024; (19(9)):e0310705 doi:10.1371/journal.pone.0310705.
PMID: 39292728 - 76
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.
Wright-Hughes A, Ford AC, Alderson SL, et al.
Health technology assessment (Winchester, England) 2024; (28(66)):1-161 doi:10.3310/BFCR7986.
PMID: 39397570 - 77
Differences in Prevalence and Psychosocial Characteristics of Irritable Bowel Syndrome According to Rome III and Rome IV Criteria in Medical and Nursing Students.
Park JH, Jeong HJ, Lee KE, et al.
Journal of neurogastroenterology and motility 2024; (30(4)):491-500 doi:10.5056/jnm22067.
PMID: 39397626 - 78
Bile acid malabsorption investigated by selenium-75-homocholic acid taurine (75SeHCAT) scans, a retrospective single-centre experience.
Vulsteke F, De Gersem R, Arts J, Vanuytsel T
Acta gastro-enterologica Belgica 2024; (87(3)):381-387 doi:10.51821/87.3.13036.
PMID: 39411791 - 79
Chronic Diarrhea Owing to Microscopic Colitis: A Cohort Study with Insights into Diagnostic Challenges and Size of the Problem.
Gad AI, Salem SM, Nofal HA, et al.
Diagnostics (Basel, Switzerland) 2024; (14(20)) doi:10.3390/diagnostics14202333.
PMID: 39451656 - 80
Recent advances in clinical practice: mastering the challenge-managing IBS symptoms in IBD.
Wellens J, Sabino J, Vanuytsel T, et al.
Gut 2025; (74(2)):312-321 doi:10.1136/gutjnl-2024-333565.
PMID: 39532478 - 81
The gut-brain axis and pain signalling mechanisms in the gastrointestinal tract.
Meerschaert KA, Chiu IM
Nature reviews. Gastroenterology & hepatology 2025; (22(3)):206-221 doi:10.1038/s41575-024-01017-9.
PMID: 39578592 - 82
Exploring congenital sucrase-isomaltase deficiency in autism spectrum disorder patients with irritable bowel syndrome symptoms: A prospective SI gene sequencing study.
Zubarioglu T, Ulgen D, Akca-Yesil S, et al.
Autism research : official journal of the International Society for Autism Research 2025; (18(1)):44-55 doi:10.1002/aur.3293.
PMID: 39676735 - 83
[Small intestine bacterial overgrowth: Myths and realities].
Guardiola-Arévalo A, Mascort Roca J, Noguerol Álvarez M, et al.
Atencion primaria 2025; (57(4)):103201 doi:10.1016/j.aprim.2024.103201.
PMID: 39799751 - 84
Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome.
Loo QY, Chuah KH, Hian WX, et al.
Journal of gastroenterology and hepatology 2025; (40(4)):884-890 doi:10.1111/jgh.16891.
PMID: 39854015 - 85
Attention in irritable bowel syndrome: A systematic review of affected domains and brain-gut axis interactions.
Akbari R, Salimi Y, Dehghani-Aarani F, Rezayat E
Journal of psychosomatic research 2025; (191()):112067 doi:10.1016/j.jpsychores.2025.112067.
PMID: 40048890 - 86
Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort).
Olsen BC, Opheim R, Kristensen VA, et al.
Inflammatory bowel diseases 2025; (31(10)):2704-2713 doi:10.1093/ibd/izaf047.
PMID: 40063582 - 87
Demystifying Carbohydrate Maldigestion: A Clinical Review.
Cash BD, Patel D, Scarlata K
The American journal of gastroenterology 2025; (120(4S)):1-11 doi:10.14309/ajg.0000000000003374.
PMID: 40249016 - 88
Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome.
Memel ZN, Shah ND, Beck KR
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2025; (40(5)):1013-1030 doi:10.1002/ncp.11307.
PMID: 40346863 - 89
Sentiment analysis and topic modeling of social media data to explore public discourse on irritable bowel syndrome.
Shankar R, Yip AW
Scientific reports 2025; (15(1)):21550 doi:10.1038/s41598-025-08599-7.
PMID: 40596686 - 90
Psychometric properties of the Hungarian Visceral Sensitivity Index (VSI-H): insights from two cross-sectional studies on self-reported IBS and gluten-related conditions.
Bertalan E, Horváth Z, Gajdos P, et al.
BMC psychology 2025; (13(1)):679 doi:10.1186/s40359-025-02918-3.
PMID: 40597234 - 91
European Consensus on Functional Bloating and Abdominal Distension-An ESNM/UEG Recommendations for Clinical Management.
Melchior C, Hammer H, Bor S, et al.
United European gastroenterology journal 2025; (13(9)):1613-1651 doi:10.1002/ueg2.70098.
PMID: 40844856 - 92
Electroacupuncture at Baliao Points Attenuates Visceral Hypersensitivity in Irritable Bowel Syndrome via Gut-Microbiota-Mast Cell-TPRV1 Axis Modulation.
Sun MY, Xing HH, Lin X, et al.
Neurogastroenterology and motility 2025; (37(11)):e70137 doi:10.1111/nmo.70137.
PMID: 40887796 - 93
Rome III Versus Rome IV Criteria for Diagnosing Irritable Bowel Syndrome in a Southeast Asian Population: Insights From the Rome Foundation Global Epidemiology Study Household Survey.
Simadibrata DM, Koo TH, Utari AP, et al.
Journal of gastroenterology and hepatology 2026; (41(1)):168-179 doi:10.1111/jgh.70174.
PMID: 41344821 - 94
Prevalence of irritable bowel syndrome in medical students: a systematic review and meta-analysis.
Ballena-Caicedo J, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, et al.
Frontiers in medicine 2025; (12()):1714085 doi:10.3389/fmed.2025.1714085.
PMID: 41473163 - 95
An umbrella review of meta-analyses on the low-FODMAP diet in IBS.
Bogdanowska-Charkiewicz D, Malinowska U, Daniluk J
Frontiers in nutrition 2025; (12()):1714281 doi:10.3389/fnut.2025.1714281.
PMID: 41550863 - 96
The mediating role of resilience in the relationship between cognitive flexibility and psychological well-being in patients with irritable bowel syndrome: a cross-sectional study.
Tamannaeifar MR, Shirani Z, Esmikhani M, Zaremohzzabieh Z
BMC gastroenterology 2026; (26(1)).
PMID: 41620640 - 97
A multidisciplinary approach to the management of disorders of gut-brain interaction: psychopharmacology, psychotherapy, and diet.
Barrera Flores FJ, Tamez JAG, Winkelman T, et al.
Frontiers in gastroenterology (Lausanne, Switzerland) 2025; (4()) doi:10.3389/fgstr.2025.1637172.
PMID: 41669534 - 98
Depression, Anxiety and Quality of Life in Adults and Older Adults with Irritable Bowel Syndrome (IBS): Observational Analysis of MEPS National Database.
Alwhaibi M, Almazrou SH
Patient preference and adherence 2026; (20()):585772 doi:10.2147/PPA.S585772.
PMID: 41710335 - 99
Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging uses.
Palenca I, Franzin SB, Pesce M, et al.
Pharmacological reports : PR 2026; (78(3)):627-640 doi:10.1007/s43440-026-00830-0.
PMID: 41729463 - 100
Economic and humanistic burden of comorbid depression among individuals with irritable bowel syndrome in the non-institutionalized US adult population.
Bhattacharya K, Arabshomali A, Lin LY, et al.
Journal of affective disorders 2026; (408()):121854 doi:10.1016/j.jad.2026.121854.
PMID: 42035802